Follow
CELLINK AB
Nasdaq First North Sweden (Sweden)
CELLINK AB is engaged in the development and commercialization of bioprinting technologies. Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications. The company's technology is used to print tissues such as liver, cartilage, skin, and even fully functional cancer tumors that can then be used to develop new cancer treatments.
Sector:
HEALTH CARE
>
Biotechnology
Medical Devices
Sector:
TECHNOLOGY
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
CLNK B
SE0013647385
Nasdaq First North Sweden
Sweden (SE)
Details of share in CELLINK AB with ticker CLNK B
Status
Active
Order book id
Amount of instruments
41 374 776
Par value
0.1000
Market cap
Currency
SEK
Segment
First North
First trading date
03 Nov 2016
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
26.00 SEK
156.3M SEK
10 Oct - 24 Oct 2016
IPO in CELLINK AB
Former ISIN
SE0009189657
Market
Nasdaq First North Sweden
Subscription period
10 Oct - 24 Oct 2016
Subscription price
Price per share
26.00 SEK
Target to raise
23 000 000 SEK
Types
Pre-money valuation
156 300 000 SEK
Subscription block size
Minimum subscription
200
Record date
Offer status
Closed
Listing status
Listed
First trading date
03 Nov 2016
Issue terms
Wide dissemination is a priority
Type
Price
Pre-money valuation
Time
Files
New issue
87.00 SEK
600M SEK
12 Jul - 12 Jul 2017
-
Share issue in CELLINK AB
Former ISIN
SE0009189657
Market
Nasdaq First North Sweden
Subscription period
12 Jul - 12 Jul 2017
Subscription price
Price per share
87.00 SEK
Target to raise
30 000 000 SEK
Types
Share issue
Pre-money valuation
600 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed to Claes Dinkelspiel, Gustavia Ny Teknik, Jonas Nordlund, Kåre Gilstring, Mangold Foundation portfolio, Mangold, Spectric Inteligence AB, Carl Bennet AB, Gryningskust Holding AB, Rikard Akhtarzand.
Type
Price
Pre-money valuation
Time
Files
New issue
92.00 SEK
666.1M SEK
06 Oct - 06 Oct 2017
-
Share issue in CELLINK AB
Former ISIN
SE0009189657
Market
Nasdaq First North Sweden
Subscription period
06 Oct - 06 Oct 2017
Subscription price
Price per share
92.00 SEK
Target to raise
30 000 000 SEK
Types
Share issue
Pre-money valuation
666 100 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed to Handelsbanken Fonder.
Type
Price
Pre-money valuation
Time
Files
New issue
132.50 SEK
1B SEK
04 Jun - 05 Jun 2018
-
Share issue in CELLINK AB
Former ISIN
SE0009189657
Market
Nasdaq First North Sweden
Subscription period
04 Jun - 05 Jun 2018
Subscription price
Price per share
132.50 SEK
Target to raise
100 250 000 SEK
Types
Share issue
Pre-money valuation
1 003 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to "reputable institutional investors" via an accelerated bookbuilding procedure by Carnegie.
Type
Price
Pre-money valuation
Time
Files
New issue
270.00 SEK
2.3B
18 Jun 2019
Share issue in CELLINK AB
Former ISIN
SE0009189657
Market
Nasdaq First North Sweden
Subscription date
18 Jun 2019
Subscription price
270.00 SEK
Price per share
270.00 SEK
Target to raise
148 500 000
Types
Share issue
Pre-money valuation
2 300 809 320
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed to institutions via a book build by Carnegie.
Type
Price
Pre-money valuation
Time
Files
New issue
297.173 SEK
26 Aug - 02 Sep 2019
-
Share issue in CELLINK AB
Former ISIN
SE0009189657
Market
Nasdaq First North Sweden
Subscription period
26 Aug - 02 Sep 2019
Subscription price
Price per share
297.173 SEK
Target to raise
200 496 139
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Set-off issue directed to the sellers of Cytena GmbH.

Christian Wildmoser, 79,623 shares, Benjamin Steimle, 42,610 shares, Andre Gross, 74,542 shares, Jonas Schöndube, 74,542 shares, Jürg F. Geigy, 110,531 shares, Peter Koltay, 28,248 shares, BioFluidix GmbH, 168,092 shares and HTGF II GmbH & Co.KG, 96,490 shares.
Comments for offer & related information
Type
Price
Pre-money valuation
Time
Files
New issue
97.00 SEK
3.78B
29 Jan - 30 Jan 2020
-
Share issue in CELLINK AB
Market
Nasdaq First North Sweden
Subscription period
29 Jan - 30 Jan 2020
Subscription price
Price per share
97.00 SEK
Target to raise
377 330 000
Types
Share issue
Pre-money valuation
3 781 500 000
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed issue, via an accelerated bookbuilding procedure organized by Carnegie Investment Bank.
Comments for offer & related information
Cellink announced after the stock exchange's closing on January 29, 2020 that they will make a directed issue of approximately 3 850 000 shares and that the process should be completed before the market opens on January 30, 2020.
Type
Price
Pre-money valuation
Time
Files
Market move
20 Apr 2020
Listing of CELLINK AB on NASDAQ STOCKHOLM
Former ISIN
SE0009189657
Move from
Nasdaq First North Sweden
Move to
NASDAQ STOCKHOLM
Status
Upcoming
Comments for listing & related information
The trading of the Company’s shares on Nasdaq Stockholm Main Market is expected to commence on Monday April 20, 2020, and the last day of trading on Nasdaq First North Growth Market is expected to be Friday 17 April.
Documents
People
Number of Employees
180 people
Paul Erik Gatenholm
CEO
Göran Nordlund
Chairman of the board
Bengt Sjöholm
Board member
Ingela Hallberg
Board member
Göran Nordlund
Board member
Artur Aira
Board member
Klementina Österberg
Board member
Hector Daniel Martinez Avila
Board member
Paul Erik Gatenholm
Board member
Andreas Albertsson
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY
Website

Address
Arvid Wallgrens Backe 20
Zip code
413 46
City/district
Gothenburg
Country
Sweden (SE)
Registration number
559050-5052
LEI code
549300FE4PT8NDXXNK85
First trade date
03 Nov 2016
Registration date
11 Feb 2016
Short name
CELLINK

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date